Loading viewer...
presentation
Format: PDF presentation
This presentation discusses the efficacy and safety of nab-sirolimus for treating advanced neuroendocrine tumors (NETs), highlighting its potential advantages over traditional mTOR inhibitors.
37 Pages
presentation
Atlas Copco Group
presentation
Bank of Ireland
presentation
Pattern Energy Group
presentation
NV5 Geospatial